LPS INDUCES IL-6 IN THE BRAIN AND IN SERUM LARGELY THROUGH TNF PRODUCTION

Dinarello, 1987, The biology of interleukin 1 and comparison to tumor necrosis factor, Immunol Lett, 16, 227, 10.1016/0165-2478(87)90151-9 Sironi, 1992, Differential sensitivity of in vivo TNF and IL-6 production to modulation by antiinflammatory drugs in mice, Int J Immunopharmacol, 14, 1045, 10.1016/0192-0561(92)90149-F Kunkel, 1988, Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression, J Biol Chem, 263, 5380, 10.1016/S0021-9258(18)60727-6 Martich, 1991, Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents, J Exp Med, 173, 1021, 10.1084/jem.173.4.1021 Jörres, 1997, Inhibition of tumour necrosis factor production in endotoxin-stimulated human mononuclear leukocytes by the prostacyclin analogue iloprost: cellular mechanisms, Cytokine, 9, 119, 10.1006/cyto.1996.0145 Renz, 1988, Release of tumor necrosis factor-a from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2and cyclic nucleotides, J Immunol, 141, 2388, 10.4049/jimmunol.141.7.2388 Spengler, 1989, Dynamics of dibutyryl cyclic AMP- and prostaglandin E2-mediated suppression of lipopolysaccharide-induced tumor necrosis factor alpha gene expression, Infect Immun, 57, 2837, 10.1128/IAI.57.9.2837-2841.1989 Hinson, 1996, Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2, Proc Natl Acad Sci USA, 93, 4885, 10.1073/pnas.93.10.4885 Zhang, 1988, Synthesis of interleukin 6 (interferon-beta2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP, J Biol Chem, 263, 6177, 10.1016/S0021-9258(18)68768-X Ghezzi, 1998, Differential contribution of R and S isomers in ketoprofen anti-inflammatory activity: role of cytokine modulation, J Pharmacol Exp Ther, 287, 969 Faggioni, 1995, Independent down-regulation of central versus peripheral TNF by LPS tolerance, Infect Immun, 63, 1473, 10.1128/IAI.63.4.1473-1477.1995 Benigni, 1996, Tumor necrosis factor receptor p55 plays a major role in centrally-mediated increases of serum IL-6 and corticosterone after intracerebroventricular injection of TNF, J Immunol, 157, 5563, 10.4049/jimmunol.157.12.5563 Di Santo, 1997, Differential effects of IL-6 on systemic and central production of TNF, Cytokine, 9, 300, 10.1006/cyto.1996.0169 Di Santo, 1996, Overexpression of IL-6 in the brain of transgenic mice increases central but not systemic proinflammatory cytokine production, Brain Res, 740, 239, 10.1016/S0006-8993(96)00865-7 Brennan, 1989, Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis, Lancet, 2, 244, 10.1016/S0140-6736(89)90430-3 Butler, 1995, Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist, Eur Cytokine Netw, 6, 225 Jansen, 1996, Release of leukemia inhibitory factor in primate sepsis. Analysis of the role of TNF-a, J Immunol, 156, 4401, 10.4049/jimmunol.156.11.4401 Reinhart, 1996, Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study, Crit Care Med, 24, 733, 10.1097/00003246-199605000-00003 Charles, 1999, Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis, J Immunol, 163, 1521, 10.4049/jimmunol.163.3.1521 Davis, 1997, Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade, Br J Rheumatol, 36, 950, 10.1093/rheumatology/36.9.950 Humes, 1980, The diminished production of arachidonic acid oxygenation products by elicited mouse peritoneal cells: possible mechanisms, J Immunol, 124, 2110, 10.4049/jimmunol.124.5.2110 Dinarello, 1986, Multiple biological activities of human recombinant interleukin 1, J Clin Invest, 77, 1734, 10.1172/JCI112495 Anderson, 1996, Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis, J Clin Invest, 97, 2672, 10.1172/JCI118717 Echtenacher, 1990, Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis, J Immunol, 145, 3762, 10.4049/jimmunol.145.11.3762 Haley, 1957, Pharmacological effects produced by intracerebral injection of drugs in the conscious mice, Br J Pharmacol, 12, 12 Lipton, 1991, Central administration of the peptide alpha-MSH inhibits inflammation in the skin, Peptides, 12, 795, 10.1016/0196-9781(91)90135-C Aggarwal, 1985, Human tumor necrosis factor. Production, purification and characterization, J Biol Chem, 260, 2345, 10.1016/S0021-9258(18)89560-6 Sironi, 1989, IL-1 stimulates IL-6 production in endothelial cells, J Immunol, 142, 549, 10.4049/jimmunol.142.2.549